Cargando…

Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas

BACKGROUND: While racial/ethnic survival disparities have been described in pediatric oncology, the impact of income has not been extensively explored. We analyzed how public insurance influences 5‐year overall survival (OS) in young patients with sarcomas. METHODS: The University of California San...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penumarthy, Neela L., Goldsby, Robert E., Shiboski, Stephen C., Wustrack, Rosanna, Murphy, Patricia, Winestone, Lena E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997066/ https://www.ncbi.nlm.nih.gov/pubmed/31838786 http://dx.doi.org/10.1002/cam4.2739

Ejemplares similares

Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma
por: Jain, Varsha, et al.
Publicado: (2019)

A U.S. population‐based study of insurance disparities in cancer survival among adolescents and young adults
por: Colton, Meryl D., et al.
Publicado: (2019)

Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma
por: Tinkle, Christopher L., et al.
Publicado: (2015)

Epidemiological study of soft‐tissue sarcomas in Ireland
por: Bhatt, Nikita, et al.
Publicado: (2015)

Clinical outcomes of non‐osteogenic, non‐Ewing soft‐tissue sarcoma of bone––experience of the Toronto Sarcoma Program
por: Veitch, Zachary W., et al.
Publicado: (2020)

Cancer survival disparities by health insurance status
por: Niu, Xiaoling, et al.
Publicado: (2013)

Clinical outcomes of radio‐hyperthermo‐chemotherapy for soft tissue sarcoma compared to a soft tissue sarcoma registry in Japan: a retrospective matched‐pair cohort study
por: Aiba, Hisaki, et al.
Publicado: (2018)

Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
por: Chen, Huan-Huan, et al.
Publicado: (2022)

Marital status and survival in patients with soft tissue sarcoma: A population‐based, propensity‐matched study
por: Zhang, Shi‐long, et al.
Publicado: (2019)

Targeted therapy for soft tissue sarcomas in adolescents and young adults
por: Steppan, Diana A, et al.
Publicado: (2017)

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
por: Orbach, Daniel, et al.
Publicado: (2018)

Extent of tumor fibrosis/hyalinization and infarction following neoadjuvant radiation therapy is associated with improved survival in patients with soft‐tissue sarcoma
por: Rao, Sneha R., et al.
Publicado: (2021)

Clinical features and outcomes of primary bone and soft tissue sarcomas in adolescents and young adults
por: Hashimoto, Kazuhiko, et al.
Publicado: (2020)

Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database reporta
por: Corey, Robert M, et al.
Publicado: (2014)

Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early‐Onset Colorectal Cancer
por: Salem, Mohamed E., et al.
Publicado: (2021)

PSAT208 A Case of Hypercalcemia From PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2022)

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018)

Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists
por: Baheti, Akshay D., et al.
Publicado: (2017)

Long-Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue Sarcomas
por: Earl, Helena M., et al.
Publicado: (1998)

Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma
por: Imai, Reiko, et al.
Publicado: (2018)

A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy
por: Niu, Isabella, et al.
Publicado: (2023)

Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0–49-year-olds in Great Britain, 1980–2005
por: Blakey, Karen, et al.
Publicado: (2014)

The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea
por: Cho, Do‐Yeon, et al.
Publicado: (2021)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
por: Carbonnaux, Mélodie, et al.
Publicado: (2019)

Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population‐based study
por: Schulpen, Maya, et al.
Publicado: (2021)

Limb‐sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high‐grade, extremity soft‐tissue sarcoma from the NCDB and SEER
por: Ramey, Stephen J., et al.
Publicado: (2018)

Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience
por: Younger, Eugenie, et al.
Publicado: (2020)

CNS Metastases from Bone and Soft Tissue Sarcomas in Children, Adolescents, and Young Adults: Are They Really So Rare?
por: Bekiesinska-Figatowska, Monika, et al.
Publicado: (2017)

PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma
por: Scheinberg, Tahlia, et al.
Publicado: (2020)

Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
por: Wustrack, Rosanna L., et al.
Publicado: (2021)

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!
por: Rastogi, Sameer, et al.
Publicado: (2019)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

Alveolar Soft Part Sarcoma of the Tongue in an Adolescent
por: Suárez, Amaranto, et al.
Publicado: (2020)

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma
por: Van Tine, Brian A., et al.
Publicado: (2019)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Socioeconomic status and survival outcomes in elderly cancer patients: A national health insurance service‐elderly sample cohort study
por: Jang, Bum‐Sup, et al.
Publicado: (2019)

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma
por: Wang, Zhi‐Ming, et al.
Publicado: (2020)

Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma
por: Wilson, Robert J., et al.
Publicado: (2015)

Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas
por: Buja, Alessandra, et al.
Publicado: (2023)

Long‐term hospitalisation rates among 5‐year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study
por: Rugbjerg, Kathrine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2euq7fl601e6i5eru1mnfdqg4e